Literature DB >> 16273646

Quantitative evaluation of long-term liver repopulation and the reconstitution of bile ductules after hepatocellular transplantation.

Yun-Wen Zheng1, Nobuhiro Ohkohchi, Hideki Taniguchi.   

Abstract

AIM: The treatment of liver disease is severely limited by a shortage of donor livers. In trying to address this growing problem, hepatocellular transplantation (HTx) has received much attention as an alternative to whole organ transplant. However, the expansion of transplanted cells is at low level, and the reconstitution of functional liver tissue is limited by this cellular property. We set up an animal model to better understand cell dose effect and the kinetics of liver repopulation following HTx.
METHODS: Dipeptidyl peptidase IV (DPPIV)-deficient rats treated with retrorsine and subjected to partial hepatectomy were infused with DPPIV-positive hepatocytes. Rats were injected with varying numbers of donor hepatocytes down to 100 cells low, and liver repopulation was examined at different time points up to 20 mo long. Repopulation was assessed by computer-aided quantitative detection.
RESULTS: Transplanted hepatocytes underwent multiple rounds of proliferation and stably repopulated the injured livers after 20 mo and at all cell doses. Transplanted cells divided 14 times within the 3-mo time period following infusion, and the liver repopulation reached a plateau between 3 and 20 mo. Approximately 90% replacement occurred. Donor-derived cells also reconstituted the bile ductules of the recipients.
CONCLUSION: The ability of transplanted hepatocytes to fully reconstitute injured livers strongly supports further investigation into the clinical potential of HTx. Additionally, the observation that transplanted hepatocytes also form components of the biliary system suggests that these cells may have bi-potential property of the stem cells.

Entities:  

Mesh:

Year:  2005        PMID: 16273646      PMCID: PMC4436636          DOI: 10.3748/wjg.v11.i39.6176

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  23 in total

1.  Flow-cytometric separation and enrichment of hepatic progenitor cells in the developing mouse liver.

Authors:  A Suzuki; Y Zheng; R Kondo; M Kusakabe; Y Takada; K Fukao; H Nakauchi; H Taniguchi
Journal:  Hepatology       Date:  2000-12       Impact factor: 17.425

2.  Evaluation of the differentiation potential of WB-F344 rat liver epithelial stem-like cells in vivo. Differentiation to hepatocytes after transplantation into dipeptidylpeptidase-IV-deficient rat liver.

Authors:  W B Coleman; K D McCullough; G L Esch; R A Faris; D C Hixson; G J Smith; J W Grisham
Journal:  Am J Pathol       Date:  1997-08       Impact factor: 4.307

3.  Amelioration of radiation-induced liver damage in partially hepatectomized rats by hepatocyte transplantation.

Authors:  C Guha; A Sharma; S Gupta; A Alfieri; G R Gorla; S Gagandeep; R Sokhi; N Roy-Chowdhury; K E Tanaka; B Vikram; J Roy-Chowdhury
Journal:  Cancer Res       Date:  1999-12-01       Impact factor: 12.701

4.  Identification of dipeptidyl peptidase IV as a protein shared by the plasma membrane of hepatocytes and liver biomatrix.

Authors:  E F Walborg; S Tsuchida; D S Weeden; M W Thomas; A Barrick; K D McEntire; J P Allison; D C Hixson
Journal:  Exp Cell Res       Date:  1985-06       Impact factor: 3.905

5.  Hepatocytes corrected by gene therapy are selected in vivo in a murine model of hereditary tyrosinaemia type I.

Authors:  K Overturf; M Al-Dhalimy; R Tanguay; M Brantly; C N Ou; M Finegold; M Grompe
Journal:  Nat Genet       Date:  1996-03       Impact factor: 38.330

6.  A pilot study of ex vivo gene therapy for homozygous familial hypercholesterolaemia.

Authors:  M Grossman; D J Rader; D W Muller; D M Kolansky; K Kozarsky; B J Clark; E A Stein; P J Lupien; H B Brewer; S E Raper
Journal:  Nat Med       Date:  1995-11       Impact factor: 53.440

7.  Cell proliferation and renewal of normal hepatocytes and bile duct cells in adult mouse liver.

Authors:  Yasushi Magami; Takeshi Azuma; Hideto Inokuchi; Shinichiro Kokuno; Fuminori Moriyasu; Keiichi Kawai; Takanori Hattori
Journal:  Liver       Date:  2002-10

8.  Long-term, near-total liver replacement by transplantation of isolated hepatocytes in rats treated with retrorsine.

Authors:  E Laconi; R Oren; D K Mukhopadhyay; E Hurston; S Laconi; P Pani; M D Dabeva; D A Shafritz
Journal:  Am J Pathol       Date:  1998-07       Impact factor: 4.307

9.  Clonal identification and characterization of self-renewing pluripotent stem cells in the developing liver.

Authors:  Atsushi Suzuki; Y W Zheng; Shin Kaneko; Masafumi Onodera; Katashi Fukao; Hiromitsu Nakauchi; Hideki Taniguchi
Journal:  J Cell Biol       Date:  2002-01-07       Impact factor: 10.539

10.  Identification of rat hepatocyte plasma membrane proteins using monoclonal antibodies.

Authors:  A L Hubbard; J R Bartles; L T Braiterman
Journal:  J Cell Biol       Date:  1985-04       Impact factor: 10.539

View more
  4 in total

1.  Proliferation of L02 human hepatocytes in tolerized genetically immunocompetent rats.

Authors:  Hu Lin; Qing Mao; Yu-Ming Wang; Li Jiang
Journal:  World J Gastroenterol       Date:  2008-04-21       Impact factor: 5.742

2.  Lasting reduction of cocaine action in neostriatum--a hydrolase gene therapy approach.

Authors:  Yang Gao; Stephen Brimijoin
Journal:  J Pharmacol Exp Ther       Date:  2009-05-28       Impact factor: 4.030

3.  Bioinformatics analysis to screen key genes implicated in the differentiation of induced pluripotent stem cells to hepatocytes.

Authors:  Rui Lin; Yufeng Wang; Kun Ji; Zhongyan Liu; Shuai Xiao; Dehua Zhou; Quanning Chen; Baomin Shi
Journal:  Mol Med Rep       Date:  2018-01-05       Impact factor: 2.952

4.  Engrafting fetal liver cells into multiple tissues of healthy adult mice without the use of immunosuppressants.

Authors:  Adas Darinskas; Renata Gasparaviciute; Mantas Malisauskas; Kristina Wilhelm; Jurij A Kozhevnikov; Evaldas Liutkevicius; Audrone Pilinkiene; Ludmilla A Morozova-Roche
Journal:  Cell Mol Biol Lett       Date:  2007-05-10       Impact factor: 5.787

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.